Advertisement
Screener

EPIRUS Biopharmaceuticals, Inc. Amortization of Intangible Assets

EPIRUS Biopharmaceuticals, Inc. Amortization of Intangible Assets

EPIRUS Biopharmaceuticals, Inc. reported Amortization of Intangible Assets of $2.18 million for the 3-month period ending 2013-12-31, per its 10-K filed 2014-03-14.

Discontinued › Expense Statement › Operating Expenses

us-gaap:AmortizationOfIntangibleAssets · last filed 2014-08-11

  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2013-12-31 was $2.18M, a 124.38% increase year-over-year.
  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2013-09-30 was $2.18M, a 123.82% increase year-over-year.
  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2013-06-30 was $2.18M, a 124.05% increase year-over-year.
  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for the quarter ending 2013-03-31 was $2.18M, a 124.15% increase year-over-year.
  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for fiscal 2013 was $8.72M, a 124.10% increase from fiscal 2012.
  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for fiscal 2012 was $3.89M, a 24.29% decline from fiscal 2011.
  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for fiscal 2011 was $5.14M, a 72.56% decline from fiscal 2010.
  • EPIRUS Biopharmaceuticals, Inc. amortization of intangible assets for fiscal 2010 was $18.74M, a 3503.08% increase from fiscal 2009.
Period endAmortization of Intangible Assets 3 monthAmortization of Intangible Assets 6 monthAmortization of Intangible Assets 9 monthAmortization of Intangible Assets 12 month
2013-12-31$2.18M
10-K · filed 2014-03-14
$4.36M
derived: sum of 2 quarters · filed 2014-03-14
$6.54M
derived: sum of 3 quarters · filed 2014-08-11
$8.72M
10-K · filed 2014-03-14
2013-09-30$2.18M
10-K · filed 2014-03-14
$4.36M
derived: sum of 2 quarters · filed 2014-08-11
$6.54M
10-Q · filed 2013-11-04
$7.51M
derived: sum of 4 quarters · filed 2014-08-11
2013-06-30$2.18M
10-Q · filed 2014-08-11
$4.36M
10-Q · filed 2014-08-11
$5.33M
derived: sum of 3 quarters · filed 2014-08-11
$6.31M
derived: sum of 4 quarters · filed 2014-08-11
2013-03-31$2.18M
10-Q · filed 2014-05-09
$3.15M
derived: sum of 2 quarters · filed 2014-03-14
$4.13M
derived: sum of 3 quarters · filed 2014-03-14
$5.10M
derived: sum of 4 quarters · filed 2014-03-14
2012-12-31$972.00K
10-K · filed 2014-03-14
$1.95M
derived: sum of 2 quarters · filed 2014-03-14
$2.92M
derived: sum of 3 quarters · filed 2014-03-14
$3.89M
10-K · filed 2014-03-14
2012-09-30$974.00K
10-K · filed 2014-03-14
$1.95M
derived: sum of 2 quarters · filed 2014-03-14
$2.92M
10-Q · filed 2013-11-04
$4.21M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30$973.00K
10-K · filed 2014-03-14
$1.95M
10-Q · filed 2013-08-05
$3.23M
derived: sum of 3 quarters · filed 2014-03-14
$4.52M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31$973.00K
10-K · filed 2014-03-14
$2.26M
derived: sum of 2 quarters · filed 2014-03-14
$3.54M
derived: sum of 3 quarters · filed 2014-03-14
$4.83M
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31$1.29M
10-K · filed 2013-03-07
$2.57M
derived: sum of 2 quarters · filed 2013-03-07
$3.86M
derived: sum of 3 quarters · filed 2013-03-07
$5.14M
10-K · filed 2014-03-14
2011-09-30$1.28M
10-K · filed 2013-03-07
$2.57M
derived: sum of 2 quarters · filed 2013-03-07
$3.85M
10-Q · filed 2012-11-08
$8.54M
derived: sum of 4 quarters · filed 2013-03-07
2011-06-30$1.28M
10-K · filed 2013-03-07
$2.57M
10-Q · filed 2012-08-07
$7.25M
derived: sum of 3 quarters · filed 2013-03-07
$11.94M
derived: sum of 4 quarters · filed 2013-03-07
2011-03-31$1.28M
10-K · filed 2013-03-07
$5.97M
derived: sum of 2 quarters · filed 2013-03-07
$10.65M
derived: sum of 3 quarters · filed 2013-03-07
$15.34M
derived: sum of 4 quarters · filed 2013-03-07
2010-12-31$4.68M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07
$9.37M
derived: sum of 2 quarters · filed 2013-03-07
$14.05M
derived: sum of 3 quarters · filed 2013-03-07
$18.74M
10-K · filed 2013-03-07
2010-09-30$4.68M
10-Q · filed 2011-11-04
$9.37M
derived: sum of 2 quarters · filed 2011-11-04
$14.05M
10-Q · filed 2011-11-04
2010-06-30$4.68M
10-Q · filed 2011-08-04
$9.37M
10-Q · filed 2011-08-04
2009-12-31$520.00K
10-K · filed 2012-03-09